Home/Filings/4/0001127602-18-012359
4//SEC Filing

Macdonald R. Loch 4

Accession 0001127602-18-012359

CIK 0001472091other

Filed

Mar 20, 8:00 PM ET

Accepted

Mar 21, 11:34 AM ET

Size

9.0 KB

Accession

0001127602-18-012359

Insider Transaction Report

Form 4
Period: 2018-03-19
Macdonald R. Loch
DirectorChief Scientific Officer
Transactions
  • Sale

    Common Stock

    2018-03-21$16.52/sh2,500$41,300573,102 total
  • Sale

    Common Stock

    2018-03-19$16.66/sh2,500$41,650580,602 total
  • Sale

    Common Stock

    2018-03-20$16.47/sh5,000$82,350575,602 total
Footnotes (4)
  • [F1]The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
  • [F2]The reported price in Column 4 is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $16.50 to $16.97 per share. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F3]The reported price in Column 4 is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $16.21 to $16.86 per share. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F4]The reported price in Column 4 is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $16.42 to $16.58 per share. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Issuer

Edge Therapeutics, Inc.

CIK 0001472091

Entity typeother

Related Parties

1
  • filerCIK 0001653008

Filing Metadata

Form type
4
Filed
Mar 20, 8:00 PM ET
Accepted
Mar 21, 11:34 AM ET
Size
9.0 KB